(Press-News.org) Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced the recipients of the 3rd Annual SCAI Early Career Research Grants. SCAI offers this initiative to support the next generation of interventional cardiologists, providing a platform for junior-level investigators within 10 years of completing an interventional cardiology fellowship to study high-priority, clinically important topics and have their findings disseminated through various professional channels. This year’s grants are funded by support from Edwards Lifesciences, Medtronic, and Shockwave Medical.
“Research funding is often limited for early career investigators striving to enhance their academic careers. SCAI's Early Career Research Grants program exemplifies SCAI's dedication to cultivating the next generation of interventional cardiologists—particularly those pursuing novel ideas,” said SCAI President George D. Dangas, MD, PhD, MSCAI. "Furthermore, we are excited to support these researchers with grants that address healthcare disparities and critical clinical areas for patients with cardiovascular disease. We look forward to their significant contributions to the field."
The 2024 SCAI Early Career Research Grant recipients were announced at a dedicated symposium at SCAI 2024 Scientific Sessions. This year’s recipients are as follows:
SCAI-Edwards Lifesciences Early Career Research Grant ($70,000): Ashwin Nathan, MD; University of Pennsylvania, Philadelphia, PA. Project: “Variation in the Distribution of Social Determinants of Health for Patients Undergoing Transcatheter Aortic Valve Replacement at 1-, 2- or 3-Star Programs.”
SCAI-Medtronic Early Career Research Grant ($65,000): Yader Sandoval, MD; Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation, Minneapolis, MN). Project: “Validation of Angiographic FFR Compared to Pressure-Wire Based FFR in Patients Undergoing Bifurcation PCI.”
SCAI-Shockwave Medical Early Career Research Grant ($50,000): Umair S. Ahmad, MD; Ohio State University, Columbus, OH. Project: “Racial Disparities in Use of Atherectomy and Intra-Vascular Lithotripsy for Percutaneous Coronary Intervention.”
The Early Career Research Grant recipients will present the results of their research at a dedicated session during the SCAI 2025 Scientific Sessions in Washington, DC. They will be invited to publish the resulting manuscripts in JSCAI. Visit the SCAI website for more information.
Members of the grant review committee included:
Sunil V. Rao, MD, FSCAI
SCAI Immediate Past President
Scientific Oversight Committee Grant Subcommittee Chair
Matthew Cavendar, MD
Harold L. Dauerman, MD, FSCAI
Kevin A. Friede, MD
George S. Hanzel, MD, FSCAI
Connie N. Hess, MD, MHS, FSCAI
Daniel M. Kolansky, MD, FSCAI
John C. Messenger, MD, FSCAI
Leah Raj, MD, FSCAI
Arnold H. Seto, MD, MPA, FSCAI
Binita Shah, MD, FSCAI
Nathaniel Smilowitz, MD, FSCAI
Molly Szerlip, MD, FSCAI
###
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions (SCAI) is a non-profit professional association with over 4,500 members representing interventional cardiologists and cardiac catheterization teams in the United States. SCAI promotes excellence in interventional cardiovascular medicine for both adults and children through education, representation, and the advancement of quality standards to enhance patient care. Follow @SCAI on Twitter for the latest heart health news.
END
Researchers at UBC and BC Cancer have developed a new artificial intelligence (AI) model that can accurately predict if a person receiving cancer care will require mental health services during their treatment journey.
The AI uses natural language processing and advanced neural networks to analyze an oncologist’s notes from their first consultation appointment with a patient. While these appointments are typically highly focused on a patient’s medical history and treatment options, the AI picks ...
The world’s leading stem cell scientists will convene in Hong Kong, SAR, 11-14 June 2025 for the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, illuminating the future of stem cell science and highlighting the most compelling research and clinical advances of the year. The meeting is co-sponsored by The University of Hong Kong, The Chinese University of Hong Kong, and Hong Kong University of Science and Technology. The Hong Kong Innovation and Technology Commission and the Hong Kong Convention and Exhibition Centre provided significant support to enable the ISSCR to bring its hallmark event to the city of ...
A wild male Sumatran orangutan (Pongo abelii) has been observed applying chewed leaves from Akar Kuning (Fibraurea tinctoria) — a climbing plant used in traditional medicine to treat wounds and conditions such as dysentery, diabetes, and malaria — to a wound on his cheek. The findings, which are published in Scientific Reports, represent the first report of suspected wound treatment by a wild animal using a plant with known medicinal properties.
Prior to this study, multiple ...
About The Study: This cohort study found that for the population without a family history of colorectal cancer (CRC), the 10-year interval between colonoscopy screenings for individuals with a first colonoscopy with findings negative for CRC could potentially be extended to 15 years. A longer interval between colonoscopy screenings could be beneficial in avoiding unnecessary invasive examinations.
Authors: Mahdi Fallah, M.D., Ph.D., of the German Cancer Research Center in Heidelberg, is the corresponding ...
About The Study: For individuals who smoked but did not achieve abstinence after treatment with varenicline, increasing the dosage enhanced abstinence versus continuing, whereas for nonabstainers initially treated with combined nicotine replacement therapy, a dosage increase or switch to varenicline enhanced abstinence and may be viable rescue strategies.
Authors: Paul M. Cinciripini, Ph.D., of the University of Texas MD Anderson Cancer Center in Houston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.4183)
Editor’s Note: Please see the article ...
The locus coeruleus (LC) is a small region of the brainstem that produces norepinephrine, a chemical with powerful effects on arousal and wakefulness which plays an important role in the body’s response to stress or panic. Now, research from the University of Chicago shows it plays a specific role in visual sensory processing as well.
In a new study published in Neuron, neuroscientists artificially increased neuronal activity in the LC by briefly shining light on genetically modified neurons. They saw that this manipulation selectively enhanced performance in non-human primates performing a visual attention task, underscoring the crucial role that attention plays in sensory ...
HOUSTON ― For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased. Researchers also found that varenicline, a cessation medication, was more effective than combined nicotine replacement therapy (CNRT), such as patches or lozenges.
The study, published today in JAMA, revealed smokers who failed to quit with varenicline in the trial’s first phase were seven times more likely to quit by the end of the second phase if varenicline ...
Long Beach, Calif. – May 2, 2024 – New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the automated extraction of key functional and physiological data from routine angiograms. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
Coronary angiography is a widely used diagnostic procedure for identifying coronary artery disease (CAD), performed in over one million patients annually in the United States. Currently, data extracted from coronary angiograms are confined to detecting blockages in the coronary arteries. However, AI technology ...
Long Beach, Calif. – May 2, 2024 – New data from the CALORI Cardiac Catheterization trial shows significant improvement in patient well-being and satisfaction without compromising safety after implementation of a liberal non-fasting strategy prior to a cardiac catheterization procedures. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
More than one million cardiac catheterizations are performed each year in the U.S. to diagnose heart problems. The risk of complications ...
Long Beach, Calif. – May 2, 2024 – Final 12-month data from the EXACT trial demonstrates safety and efficacy results for a vascular endothelial growth factor (VEGF) gene therapy treatment for patients who have advanced coronary artery disease (CAD). The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
CAD, also known as coronary heart disease or ischemic heart disease, affects about 20.5 million U.S. adults – making it the most common type of heart disease in the ...
